Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation

Xenotransplantation

Volumn 22, Issue 2, 2015, Pages 85-94

  Salama, Apolline ^a,b   Evanno, Gwénaëlle ^a   Harb, Jean ^a   Soulillou, Jean Paul ^a,c  

^a INSERM   (France)

^b Societe D'Acce Leration du Transfert de Technologies SATT Ouest Valorisation   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

anti Neu5Gc antibody; heart valves; Neu5Gc; neuraminic acid; pancreatic islets; sialic acid; xenotransplantation

Indexed keywords

GLYCOLYL FORM OF NEURAMINIC ACID; NEURAMINIC ACID; UNCLASSIFIED DRUG; HETEROPHILE ANTIBODY; HETEROPHILE ANTIGEN; N-GLYCOLYLNEURAMINIC ACID; NEURAMINIC ACID DERIVATIVE;

ENDOTHELIUM CELL; ERYTHROCYTE MEMBRANE; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; KIDNEY PERFUSION; MASS SPECTROMETRY; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; XENOTRANSPLANTATION; ADVERSE EFFECTS; ANIMAL; ANIMAL MODEL; BLOOD; EXPERIMENTAL ANIMAL; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; ORGAN TRANSPLANTATION; PIG; PRIMATE; XENOGRAFT;

ANIMALS; ANIMALS, LABORATORY; ANTIBODIES, HETEROPHILE; ANTIGENS, HETEROPHILE; HUMANS; IMMUNITY, INNATE; MODELS, ANIMAL; NEURAMINIC ACIDS; ORGAN TRANSPLANTATION; PRIMATES; SUS SCROFA; TRANSPLANTATION, HETEROLOGOUS;

EID: 84926476077     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12142     Document Type: Review

References (103)

1. Varki A, Cummings RD, Esko JD, et al., eds. Essentials of Glycobiology, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2009.
2. Takeuchi Y, Porter CD, Strahan KM, et al. Sensitization of cells and retroviruses to human serum by (αl-3) galactosyltransferase. Nature 1996; 379: 85-88.
3. Varki NM, Strobert E, Dick EJ, Benirschke K, Varki A,. Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology. Annu Rev Pathol 2011; 6: 365-393.
4. Schouten M, Wiersinga WJ, Levi M, van der Poll T,. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83: 536-545.
5. Oriol R, Le Pendu J, Mollicone R,. Genetics of ABO, H, Lewis, X and related antigens. Vox Sang 1986; 51: 161-171.
6. Cooper DK, Koren E, Oriol R,. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141: 31-58.
7. Galili U,. The α-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 2005; 83: 674-686.
8. Robson SC, Am Esch JS, Bach FH,. Factors in xenograft rejection. Ann N Y Acad Sci 1999; 875: 261-276.
9. Cowan PJ, Robson SC, D'Apice AJF,. Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant 2011; 16: 214-221.
10. Cozzi E, White DJ,. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964-966.
11. Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM,. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730-1737.
12. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20: 251-255.
13. Griesemer AD, Hirakata A, Shimizu A, et al. Results of gal-knockout porcine thymokidney xenografts. Am J Transplant 2009; 9: 2669-2678.
14. Hisashi Y, Yamada K, Kuwaki K, et al. Rejection of cardiac xenografts transplanted from α-1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant 2008; 8: 2516-2526.
15. Kuwaki K, Tseng Y-L, Dor FJMF, et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29-31.
16. Phelps CJ, Koike C, Vaught TD, et al. Production of α1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411-414.
17. Tseng Y-L, Kuwaki K, Dor FJMF, et al. α1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80: 1493-1500.
18. Galili U,. Induced anti-non gal antibodies in human xenograft recipients. Transplantation 2012; 93: 11-16.
19. Byrne GW, Stalboerger PG, Davila E, et al. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 2008; 15: 268-276.
20. Zhu A,. Binding of human natural antibodies to non αGal xenoantigens on porcine erythrocytes. Transplantation 2000; 69: 2422-2428.
21. Ezzelarab M, Garcia B, Azimzadeh A, et al. The innate immune response and activation of coagulation in α1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009; 87: 805-812.
22. Dufrane D, Goebbels R-M, Gianello P,. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010; 90: 1054-1062.
23. Galili U, Tibell A, Samuelsson B, Rydberg L, Groth C,. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 1995; 59: 1549-1556.
24. Satake M, Kawagishi N, Kumagai-Braesch M, et al. Specificity of human xenoantibodies formed in response to fetal porcine isletlike cell clusters. Transplant Proc 1994; 26: 1122.
25. Vabres B, Le Bas-Bernardet S, Riochet D, et al. hCTLA4-Ig transgene expression in keratocytes modulates rejection of corneal xenografts in a pig to non-human primate anterior lamellar keratoplasty model. Xenotransplantation 2014; doi: 10.1111/xen.12107. [Epub ahead of print]
26. Thompson P, Badell IR, Lowe M, et al. Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am J Transplant 2011; 11: 2593-2602.
27. Chung CH, Mirakhur B, Chan E, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose. N Engl J Med 2008; 358: 1109-1117.
28. Chou H-H, Takematsu H, Diaz S, et al. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci U S A 1998; 95: 11751-11756.
29. Malykh YN, Shaw L, Schauer R,. The role of CMP-N-acetylneuraminic acid hydroxylase in determining the level of N-glycolylneuraminic acid in porcine tissues. Glycoconj J 1998; 15: 885-893.
30. Schauer R,. Sialic acids: fascinating sugars in higher animals and man. Zoology 2004; 107: 49-64.
31. Bardor M, Nguyen DH, Diaz S, Varki A,. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem 2005; 280: 4228-4237.
32. Tangvoranuntakul P, Gagneux P, Diaz S, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A 2003; 100: 12045-12050.
33. Padler-Karavani V, Yu H, Cao H, et al. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology 2008; 18: 818-830.
34. Zhu A, Hurst R,. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002; 9: 376-381.
35. Waldman JP, Brock LG, Rees MA,. A human-specific mutation limits nonhuman primate efficacy in preclinical xenotransplantation studies. Transplantation 2014; 97: 385-390.
36. Miwa Y, Kobayashi T, Nagasaka T, et al. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation 2004; 11: 247-253.
37. Miyagawa S, Ueno T, Nagashima H, Takama Y, Fukuzawa M,. Carbohydrate antigens. Curr Opin Organ Transplant 2012; 17: 174-179.
38. Padler-Karavani V, Varki A,. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation 2011; 18: 1-5.
39. Kobayashi T, Yokoyama I, Suzuki A, et al. Lack of antibody production against Hanganutziu-Deicher (H-D) antigens with N-glycolylneuraminic acid in patients with porcine exposure history. Xenotransplantation 2000; 7: 177-180.
40. Bouhours D, Bouhours JF,. Tissue-specific expression of GM3(NeuGc) and GD3(NeuGc) in epithelial cells of the small intestine of strains of inbred rats. Absence of NeuGc in intestine and presence in kidney gangliosides of brown Norway and spontaneously hypertensive rats. J Biol Chem 1988; 263: 15540-15545.
41. Bouhours D, Pourcel C, Bouhours J-F,. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Galα1-3Gal), blood group H determinant and N-glycolylneuraminic acid. Glycoconj J 1996; 13: 947-953.
42. Diswall M, Ångström J, Karlsson H, et al. Structural characterization of α1,3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies. Xenotransplantation 2010; 17: 48-60.
43. Omori T, Nishida T, Komoda H, et al. A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression. Xenotransplantation 2006; 13: 455-464.
44. Komoda H, Miyagawa S, Kubo T, et al. A study of the xenoantigenicity of adult pig islets cells. Xenotransplantation 2004; 11: 237-246.
45. Maeda A, Ueno T, Nakatsu S, et al. A lectin microarray study of glycoantigens in neonatal porcine islet-like cell clusters. J Surg Res 2013; 183: 412-418.
46. Cohen D, Miyagawa Y, Mehra R, et al. Distribution of non-gal antigens in pig cornea: relevance to corneal xenotransplantation. Cornea 2014; 33: 390-397.
47. Davies LRL, Varki A,. Why is n-glycolylneuraminic acid rare in the vertebrate brain? Top Curr Chem 2013; doi: 10.1007/128-2013-419 [Epub ahead of print].
48. Scobie L, Padler-Karavani V, Le Bas-Bernardet S, et al. Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol 2013; 191: 2907-2915.
49. Naso F, Gandaglia A, Bottio T, et al. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. Xenotransplantation 2013; 20: 252-261.
50. Park CS, Oh S-S, Kim YE, et al. Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults. J Heart Valve Dis 2013; 22: 222-229.
51. Stone KR, Abdel-Motal UM, Walgenbach AW, Turek TJ, Galili U,. Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation. Transplantation 2007; 83: 211-219.
52. Manji RA, Ekser B, Menkis AH, Cooper DKC,. Bioprosthetic heart valves of the future. Xenotransplantation 2014; 21: 1-10.
53. Manji RA, Zhu LF, Nijjar NK, et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006; 114: 318-327.
54. Jeong H-J, Adhya M, Park H-M, Kim Y-G, Kim B-G,. Detection of Hanganutziu-Deicher antigens in O-glycans from pig heart tissues by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Xenotransplantation 2013; 20: 407-417.
55. Burlak C, Bern M, Brito AE, et al. N-linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens. Xenotransplantation 2013; 20: 277-291.
56. Wormald MR, Rudd PM, Harvey DJ, et al. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry (Mosc) 1997; 36: 1370-1380.
57. Pirofsky B, Ramirez-Mateos JC, August A,. "Foreign Serum" heterophile antibodies in patients receiving antithymocyte antisera. Blood 1973; 42: 385-393.
58. Gitelman SE, Gottlieb PA, Rigby MR, et al. Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol 2013; 1: 306-316.
59. Higashi H, Naiki M, Matuo S, Okouchi K,. Antigen of "serum sickness" type of heterophile antibodies in human sera: identification as gangliosides with N-glycolylneuraminic acid. Biochem Biophys Res Commun 1977; 79: 388-395.
60. Merrick JM, Zadarlik K, Milgrom F,. Characterization of the Hanganutziu-Deicher (serum-sickness) antigen as gangliosides containing N-glycolylneuraminic acid. Int Arch Allergy Appl Immunol 1978; 57: 477-480.
61. Pham T, Gregg CJ, Karp F, et al. Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium. Blood 2009; 114: 5225-5235.
62. Ducloux D, Courivaud C, Bamoulid J, et al. Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients. J Am Soc Nephrol 2014; 25: 1349-1356.
63. Hanganutziu M,. Hémagglutinines hétérogénétiques après injection de sérum de cheval. CR Séances Soc Biol 1924; 91: 1457-1459.
64. Kobayashi T, Suzuki A, Yokoyama I, et al. Immunogenicity of Hanganutziu-Deicher antigens in pig-to-human xenotransplantation. Transplant Proc 2000; 32: 874.
65. Blixt O, Kumagai-Braesch M, Tibell A, Groth CG, Holgersson J,. Anticarbohydrate antibody repertoires in patients transplanted with fetal pig islets revealed by glycan arrays. Am J Transplant 2009; 9: 83-90.
66. Magnusson S, Månsson J-E, Strokan V, et al. Release of pig leukocytes during pig kidney perfusion and characterization of pig lymphocyte carbohydrate xenoantigens. Xenotransplantation 2003; 10: 432-445.
67. Banda K, Gregg CJ, Chow R, Varki NM, Varki A,. Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid. J Biol Chem 2012; 287: 28852-28864.
68. Padler-Karavani V, Tremoulet AH, Yu H, et al. A simple method for assessment of human anti-Neu5Gc antibodies applied to kawasaki disease. PLoS ONE 2013; 8: e58443.
69. Morito T, Kano K, Milgrom F,. Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases. J Immunol 1982; 129: 2524-2528.
70. Soulillou J-P,. Missing links in multiple sclerosis etiology. A working connecting hypothesis. Med Hypotheses 2013; 80: 509-516.
71. Rodríguez-Zhurbenko N, Martínez D, Blanco R, et al. Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties. Eur J Immunol 2013; 43: 826-837.
72. Le Bas-Bernardet S, Tillou X, Poirier N, et al. Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons. Transplant Proc 2011; 43: 3426-3430.
73. Cooper DKC,. A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent) 2012; 25: 49-57.
74. Reemtsma K, McCracken BH, Schlegel JU, et al. Renal heterotransplantation in man. Ann Surg 1964; 160: 384-408.
75. Reemtsma K,. Renal heterotransplantation from nonhuman primates to man. Ann N Y Acad Sci 1969; 162: 412-418.
76. Starzl TE, Marchioro TL, Peters GN, et al. Renal heterotransplantation from baboon to man: experience with 6 cases. Transplantation 1964; 2: 752-776.
77. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB,. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254: 3321-3329.
78. Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet 1993; 341: 65-71.
79. Michaels MG, Kaufman C, Volberding PA, et al. Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up. Transplantation 2004; 78: 1582-1589.
80. Grabenwöger M, Fitzal F, Gross C, et al. Different modes of degeneration in autologous and heterologous heart valve prostheses. J Heart Valve Dis 2000; 9: 104-109; discussion 110-111.
81. Loyens M, Thuny F, Grisoli D, et al. Link between endocarditis on porcine bioprosthetic valves and allergy to pork. Int J Cardiol 2013; 167: 600-602.
82. Rispens T, Derksen NIL, Commins SP, Platts-Mills TA, Aalberse RC,. IgE production to α-gal is accompanied by elevated levels of specific IgG1 antibodies and low amounts of IgE to blood group B. PLoS ONE 2013; 8: e55566.
83. Dvoránková B, Broz L, Pafcuga I, Kapounková Z, Königová R,. The role of skin bank in the treatment of severely burnt patients. Acta Chir Plast 2004; 46: 51-55.
84. Tahara H, Ide K, Basnet NB, et al. Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice. J Immunol 2010; 184: 3269-3275.
85. Kavaler S, Morinaga H, Jih A, et al. Pancreatic β-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency. FASEB J 2011; 25: 1887-1893.
86. Naito Y, Takematsu H, Koyama S, et al. Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. Mol Cell Biol 2007; 27: 3008-3022.
87. Hedlund M, Tangvoranuntakul P, Takematsu H, et al. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol Cell Biol 2007; 27: 4340-4346.
88. Lutz AJ, Li P, Estrada JL, et al. Double knockout pigs deficient in N-glycolylneuraminic acid and Galactose α-1,3-Galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 2013; 20: 27-35.
89. Conchon S, Perota A, Concordet J-P, et al. Generation of CMAH-/-piglets on GAL-/-genetic background (oral communication 8: Tg pigs and animal models). Xenotransplantation 2013; 20: 368-371.
90. Kwon D-N, Lee K, Kang M-J, et al. Production of biallelic CMP-Neu5Ac hydroxylase knock-out pigs. Sci Rep 2013; 3: 1981.
91. Martin MJ, Muotri A, Gage F, Varki A,. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005; 11: 228-232.
92. Park J-Y, Park M-R, Bui H-T, et al. α1,3-galactosyltransferase deficiency in germ-free miniature pigs increases N-glycolylneuraminic acids as the xenoantigenic determinant in pig-human xenotransplantation. Cell Reprogram 2012; 14: 353-363.
93. Park J-Y, Park M-R, Kwon D-N, et al. Alpha 1,3-galactosyltransferase deficiency in pigs increases sialyltransferase activities that potentially raise non-gal xenoantigenicity. Biomed Res Int 2011; 2011: e560850.
94. Deschamps J-Y, Roux FA, Saï P, Gouin E,. History of xenotransplantation. Xenotransplantation 2005; 12: 91-109.
95. Taniguchi S, Cooper DK,. Clinical xenotransplantation: past, present and future. Ann R Coll Surg Engl 1997; 79: 13-19.
96. Hitchcock CR, Kiser JC, Telander RL, Seljeskog EL,. Baboon renal grafts. JAMA 1964; 189: 934-937.
97. Reemtsma K, McCracken BH, Schlegel JU, Pearl M,. Heterotransplantation of the kidney: two clinical experiences. Science 1964; 143: 700-702.
98. Reemtsma K,. Xenotransplantation: a historical perspective. ILAR J 1995; 37: 9-12.
99. Rowlands DT, Kirkpatrick CH, Vatter AE, Wilson WE,. Immunologic studies in human organ transplantation. IV. Serologic and pathologic studies following heterotransplantation of the kidney. Am J Pathol 1967; 50: 605-622.
100. Hume D,. Discussion of reemtsma paper. Ann Surg 1964; 160: 409.
101. Traeger J, Fries D, Perrin J,. Heterotransplantation chez l'homme. Premier résultats [Heterotransplantation in man. First results]. Proc Eur Dial Transplant Assoc 1965; 2: 214.
102. Cortesini R, Casciani C, Cucchiara G,. Heterotransplantation in primates: current state of affairs. In:, Balner H, ed. Infection and Immunosuppression in Subhuman Primates. Copenhagen: Munksgaard, 1969: 239.
103. Rose AG, Cooper DK, Human PA, Reichenspurner H, Reichart B,. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. J Heart Lung Transplant 1991; 10: 223-234.